P2C-1F11
An anti-RBD (SARS-CoV-2 Spike) monoclonal antibody.
General information
P2C-1F11 is an RBD-specific (SARS-CoV-2 Spike) human monoclonal antibody capable of neutralizing the (pseudo)virus in vitro. It was identified in a memory B cell of a convalescent individual (Ju et al., 2020).
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Spike protein Crystallization Novel compound Biophysical assay Protein factor In vitro Antibody |
patient sera; in vitro biophysical assay; Huh-7 cells; Vero E6 cells; (HIV-1) SARS-CoV-2 Spike-pseudotyped virus; SARS-CoV-2 strain Beta/Shenzhen/SZTH-003/2020, EPI_ISL_406594 | 49.96 | The antibody bound RBD and neutralized SARS-CoV-2 live/pseudo-virus in vitro. |
May/26/2020 |
